ADVANCED (INOPERABLE) NON SMALL CELL LUNG CANCER

Clinical trials for ADVANCED (INOPERABLE) NON SMALL CELL LUNG CANCER explained in plain language.

Never miss a new study

Get alerted when new ADVANCED (INOPERABLE) NON SMALL CELL LUNG CANCER trials appear

Sign up with your email to follow new studies for ADVANCED (INOPERABLE) NON SMALL CELL LUNG CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Completed 1

Scientists check if common pill alters cancer drug

Knowledge-focused Completed

This study aimed to understand how a common antifungal drug (itraconazole) affects the blood levels of a lung cancer drug (AZD9291, now known as osimertinib). It involved 39 adults with a specific type of advanced lung cancer that had worsened after previous treatment. The main g…

Matched conditions: ADVANCED (INOPERABLE) NON SMALL CELL LUNG CANCER

Phase: PHASE1 • Sponsor: AstraZeneca • Aim: Knowledge-focused

Last updated Mar 30, 2026 14:30 UTC

ADVANCED (INOPERABLE) NON SMALL CELL LUNG CANCER

Get alerted when new ADVANCED (INOPERABLE) NON SMALL CELL LUNG CANCER trials appear

Scientists check if common pill alters cancer drug